(Q39386520)

11 September 2017

1 reference

title

Recent advances in therapeutic delivery systems of bacteriophage and bacteriophage-encoded endolysins (English)

1 reference

11 September 2017

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28633592%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

J Mark Sutton

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28633592%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Toby Jenkins

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28633592%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

author name string

Scarlet Milo

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28633592%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

publication date

1 July 2017

1 reference

11 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28633592%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28633592%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28633592%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

543-556

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28633592%20AND%20SRC:MED&resulttype=core&format=json

Revisiting phage therapy: new applications for old resources.

1 June 2020

cites work

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

THE DISCOVERY OF THE "BACTERIOPHAGE."

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Bacteriophages: evolution of the majority

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

The future of bacteriophage biology

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Phage Therapy in Bacterial Infections Treatment: One Hundred Years After the Discovery of Bacteriophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Additive approach for inactivation of Escherichia coli O157:H7, Salmonella, and Shigella spp. on contaminated fresh fruits and vegetables using bacteriophage cocktail and produce wash

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Application of bacteriophages for detection of foodborne pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Bacteriophages and their implications on future biotechnology: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Natural solution to antibiotic resistance: bacteriophages 'The Living Drugs'

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Phage approved in food, why not as a therapeutic?

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Bacteriophage therapies re-enter clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa ; a preliminary report of efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

The potential of phages to prevent MRSA infections

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Adapting Drug Approval Pathways for Bacteriophage-Based Therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

The factors affecting effectiveness of treatment in phages therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Bacteriophage Associated Silicon Particles: Design and Characterization of a Novel Theranostic Vector with Improved Payload Carrying Potential

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Hybrid Nanomaterial Complexes for Advanced Phage-guided Gene Delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Optimized Formulation of a Thermostable Spray-Dried Virus-Like Particle Vaccine against Human Papillomavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Phage-based detection of bacterial pathogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Engineered phage-based therapeutic materials inhibit Chlamydia trachomatis intracellular infection

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Going viral: designing bioactive surfaces with bacteriophage

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Counteracting selection for antibiotic-resistant bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Temperate and lytic bacteriophages programmed to sensitize and kill antibiotic-resistant bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Role of lung epithelial cells in defense against Klebsiella pneumoniae pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Encapsulation of Bacteriophage in Liposome Accentuates Its Entry in to Macrophage and Shields It from Neutralizing Antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

A first step toward liposome-mediated intracellular bacteriophage therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Phage neutralization by sera of patients receiving phage therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Bacteriophage-loaded nanostructured lipid carrier: improved pharmacokinetics mediates effective resolution of Klebsiella pneumoniae-induced lobar pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Phospholipid vesicles encapsulated bacteriophage: A novel approach to enhance phage biodistribution

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Biomimetic aqueous-core lipid nanoballoons integrating a multiple emulsion formulation: a suitable housing system for viable lytic bacteriophages

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Enhancement of the antimicrobial properties of bacteriophage-K via stabilization using oil-in-water nano-emulsions

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Elucidation of the mechanisms of action of Bacteriophage K/nano-emulsion formulations against S. aureus via measurement of particle size and zeta potential

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Microencapsulation of bacteriophage felix O1 into chitosan-alginate microspheres for oral delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Phage-bacterium war on polymeric surfaces: can surface-anchored bacteriophages eliminate microbial infections?

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Optimizing Bacteriophage Surface Densities for Bacterial Capture and Sensing in Quartz Crystal Microbalance with Dissipation Monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Immobilization of Active Bacteriophages on Polyhydroxyalkanoate Surfaces.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Poly-γ-Glutamic Acid: Biodegradable Polymer for Potential Protection of Beneficial Viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

RETRACTED: Stabilization of vaccines and antibiotics in silk and eliminating the cold chain

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Stabilization of viruses by encapsulation in silk proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Aerosol phage therapy efficacy in Burkholderia cepacia complex respiratory infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Bacteriophage Delivery by Nebulization and Efficacy Against Phenotypically Diverse Pseudomonas aeruginosa from Cystic Fibrosis Patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

In vitro lung delivery of bacteriophages KS4-M and ΦKZ using dry powder inhalers for treatment of Burkholderia cepacia complex and Pseudomonas aeruginosa infections in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Instability of bacteriophages in spray-dried trehalose powders is caused by crystallization of the matrix.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Feasibility of spray drying bacteriophages into respirable powders to combat pulmonary bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Effects of environmental and clinical interferents on the host capture efficiency of immobilized bacteriophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Poly(N-isopropylacrylamide-co-allylamine) (PNIPAM-co-ALA) nanospheres for the thermally triggered release of Bacteriophage K.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Role of hyaluronidase in subcutaneous spread and growth of group A streptococcus

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Dual Functionalized Bacteriophage Qβ as a Photocaged Drug Carrier

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Development of virus-like particles for diagnostic and prophylactic biomedical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Lysins: the arrival of pathogen-directed anti-infectives

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Insights into the regulation of bacteriophage endolysin: multiple means to the same end.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Mobilization of Genomic Islands of Staphylococcus aureus by Temperate Bacteriophage.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Effective removal of staphylococcal biofilms by the endolysin LysH5.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Intravitreal injection of the chimeric phage endolysin Ply187 protects mice from Staphylococcus aureus endophthalmitis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Bacteriophage-Derived Peptidase CHAP(K) Eliminates and Prevents Staphylococcal Biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Rapid degradation of Streptococcus pyogenes biofilms by PlyC, a bacteriophage-encoded endolysin.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

A bacteriolytic agent that detects and kills Bacillus anthracis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Identification and characterisation of the putative phage-related endolysins through full genome sequence analysis in Acinetobacter baumannii ATCC 17978.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Antimycobacterial Activities of Endolysins Derived From a Mycobacteriophage, BTCU-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Endolysins: redefining antibacterial therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Combination therapy with lysin CF-301 and antibiotic is superior to antibiotic alone for treating methicillin-resistant Staphylococcus aureus-induced murine bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Breaking barriers: expansion of the use of endolysins as novel antibacterials against Gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Engineered endolysin-based "Artilysins" to combat multidrug-resistant gram-negative pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Efficacy of Artilysin Art-175 against Resistant and Persistent Acinetobacter baumannii.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

From endolysins to Artilysin®s: novel enzyme-based approaches to kill drug-resistant bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

'Artilysation' of endolysin λSa2lys strongly improves its enzymatic and antibacterial activity against streptococci.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Physicochemical characterization of the staphylolytic LysK enzyme in complexes with polycationic polymers as a potent antimicrobial

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

The truncated phage lysin CHAP(k) eliminates Staphylococcus aureus in the nares of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Characterization of the staphylococcal bacteriophage lysin CHAP(K).

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Thermally triggered release of the bacteriophage endolysin CHAPK and the bacteriocin lysostaphin for the control of methicillin resistant Staphylococcus aureus (MRSA)

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

In vivo characterization of Lactobacillus johnsonii FI9785 for use as a defined competitive exclusion agent against bacterial pathogens in poultry.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Expression and delivery of an endolysin to combat Clostridium perfringens

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

Triggered Release of Bacteriophage K from Agarose/Hyaluronan Hydrogel Matrixes by Staphylococcus aureus Virulence Factors

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FTDE-2017-0040

21 January 2018

Identifiers

DOI

10.4155/TDE-2017-0040

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28633592%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

1 reference